Software to clarify MRI scan analysis

3D Net Perfusion, new software developed by The Institute of Cancer Research (ICR) working with Biotronics3D, aims to improve the accuracy of MRI scan analysis and treatment efficacy by extracting data from tumour images and transforming it into usable information. In addition, the analytical tool provides a method to visualise and measure blood supply to cancers - a crucial factor in tumour growth.

Resulting from trials at the ICR led by Professor Martin Leach, David Collins and James d’Arcy, the software is currently used in 10 research centres. Work continues between the ICR scientists and Biotronics3D to enhance the product, which has attracted significant investment from London-based venture specialist Longbow Capital LLP.

01.09.2009

Article •

Novel cancer treatment options

During a gathering of clinicians, scientists and economists at this year's Medical Technology Congress (Treffpunkt für Medizintechnik) held in Berlin's Charité Hospital, all 17 lectures focused on…

Article •

Welcome to ESTRO 27

More than 4,500 cancer and radiotherapy specialists will gather in Göteborg, Sweden, this September for the 27th annual congress of ESTRO. ESTRO 27 is to be held between the 14th and 18th September…

News • Cancer imaging

MRI 2.0 lights up cancerous tissue

Synthetic correlated diffusion makes cancerous tissue glow in medical images could help doctors more accurately detect and track the progression of cancer over time.